Osteoarthritis Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1067432
  • December 2021
  • Pharmaceuticals
  • 154 Pages
Report Description

This report is a comprehensive study that examines the Osteoarthritis industry in depth. With reference to key regions and major nations, the study specifies the product type of Osteoarthritis as well as its use in various industrial verticals. Furthermore, the report identified and analysed all of the top companies functioning in the global Osteoarthritis market arena, comparing and contrasting them based on market revenue, yearly sales volume, historical growth rate, and company strategies. The worldwide Osteoarthritis market research offers a business strategy for current market participants to strengthen their market positions based on all of these findings. Furthermore, the paper recommends a market entry strategy for newcomers to the sector.

The top vendors and distributors operating in all of the major regions have also been highlighted in the Osteoarthritis market report. This data and research should aid market players in strengthening their market distribution networks and expanding their geographic reach.
 
Osteoarthritis Market Strategic Analysis 

The market was studied using several marketing methodologies such as Porter's Five Forces Analysis, player positioning analysis, SWOT analysis, market share analysis, and value chain analysis in the Osteoarthritis market study. The market dynamics and factors such as the threat of a Osteoarthritis substitute, the threat of new entrants into the Osteoarthritis market, buyer bargaining power, supplier bargaining power to Osteoarthritis providing companies, and internal rivalry among Osteoarthritis providers are analysed in Porter's Five Forces analysis to provide the report's readers with a detailed view of the current market dynamics.

This analysis assists report users in evaluating the Osteoarthritis market based on various parameters such as economies of scale, switching costs, brand loyalty, existing distribution channels, capital investments, manufacturing rights & patents, government regulations, advertising impact, and consumer preference impact. This simplified data is expected to aid the industry's key decision-makers in their decision-making process. Furthermore, this study answers the crucial question of whether or not new entrants should enter the Osteoarthritis industry.
 
Osteoarthritis Market Key Trends Analysis

The important factors influencing the growth of the Osteoarthritis market have been examined in this report. The driving factors that are boosting demand for Osteoarthritiss and the restraining factors that are slowing growth of the Osteoarthritis industry are addressed in depth, as well as their implications for the worldwide Osteoarthritis market. In addition, the published analysis identifies and discusses in detail the trends that are driving the market and impacting its growth. In addition, other qualitative variables such as risks connected with operations and key problems faced by market players are covered in the report.

Osteoarthritis Market Key Segment Analysis

By segmenting the market by product type, application, and geography, the study provides a clear picture of the Osteoarthritis industry. On the basis of current and future trends, all segments of the Osteoarthritis industry have been examined. The market and its divisions are forecasted for the years 2021 through 2028. The study identifies the categories that are contributing the most to total market revenue growth, as well as the factors that are supporting their growth.

The research will provide a detailed qualitative and quantitative product type segment analysis for the years 2021 to 2028.

The report study analyses and includes a variety of prospective prospects and aspects affecting various applications.
 
Osteoarthritis Market Regional Trends and Market Player’s Analysis

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are the regions in which the market is divided. In 2020, the worldwide Osteoarthritis market was dominated by North America. The Asia Pacific region is expected to have the highest CAGR for the Osteoarthritis market throughout the projected period.


 
The market revenue, market shares, business strategies, recent developments, and growth rates of major players with substantial market shares in the global Osteoarthritis market are all examined. These firms' recent developments, such as new solution/product launches, research projects, acquisitions, geographic expansions, and technological advancements, are taken into account when determining their position in the Osteoarthritis market. All important stakeholders in the Osteoarthritis value chain and technological ecosystem are expected to benefit from the insights offered in the Osteoarthritis market research study.

In order to provide a broader understanding of the top competitors in the Osteoarthritis market, the research includes a company market share analysis. Ampio Pharmaceuticals, Biosplice Therapeutics, Symic Bio, UnicoCell Biomed CO. LTD, Eupraxia Pharmaceuticals Inc., Eli Lilly and Company, Xalud Therapeutics, Inc., ICM Biotech Australia Pty Ltd., Taiwan Liposomal Company, Gwo Xi Stem Cell Applied Technology Co., Ltd., K-STEMCELL, Centrexion Therapeutics, Techfields Pharma, AstraZeneca are among the major participants in the global Osteoarthritis industry.
 
Scope of the report
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2021
Forecast Period Covered 2021-2028
Units for value Revenue in USD million and CAGR from 2021 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Ampio Pharmaceuticals, Biosplice Therapeutics, Symic Bio, UnicoCell Biomed CO. LTD, Eupraxia Pharmaceuticals Inc., Eli Lilly and Company, Xalud Therapeutics, Inc., ICM Biotech Australia Pty Ltd., Taiwan Liposomal Company, Gwo Xi Stem Cell Applied Technology Co., Ltd., K-STEMCELL, Centrexion Therapeutics, Techfields Pharma, AstraZeneca
 
Major Highlights of the Osteoarthritis Market report study:
  • An in-depth examination of the global Osteoarthritis industry will be published soon.
  • The study examines the global Osteoarthritis market and offers major actionable information to its players.
  • The research has taken into account all key events in the recent past, providing users with up-to-date industry information.
  • The report study is expected to aid the industry's key decision-makers in their decision-making process.
  • Data on market intelligence, changing market dynamics, existing and predicted market trends, and so on are included in the report.
  • The research includes a detailed examination of the macroeconomic and microeconomic aspects that influence the global Osteoarthritis industry.
  • The Market Ecosystem and Adoption in Different Markets
  • The global Osteoarthritis market is being shaped by several major trends.
  • The size of the Osteoarthritis market in terms of revenue has been measured in the past and will be measured in the future in USD million.
  • Consumer preference patterns and recent industrial developments
  • The worldwide Osteoarthritis market's competitive landscape and player positioning analysis
  • Major players' key goods and solutions, as well as their business strategies
  • Recommendations for new market entrants as well as existing market participants.
  • The study of niche and potential segments (product type, application, and regions/countries) predicts that promising growth will be noticed.
  • Operating players in the market encounter a number of significant hurdles.
  • An examination of the major risks involved in market operations
 
The report segment of the global Osteoarthritis market as follows:
Global Osteoarthritis Market: By Product Type

  • Monoclonal Antibody
  • Peptides
  • Polymer
  • Small molecule
  • Gene therapy

Global Osteoarthritis Market: By Application
  • Application I
  • Application II
  • Application III

Global Osteoarthritis Market: By Region
  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China 
    • Japan
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

The report study is drafted to provide actionable insights to the following mentioned audience:
  • Institutes of research and consulting firms
  • Companies are attempting to get into the Osteoarthritis market.
  • Universities and students
  • Other companies in the Osteoarthritis market include solution providers, product producers, service providers, and others.
  • Private companies and government agencies that are linked
  • Individuals interested in learning more about the Osteoarthritis market

Manufacturers and Segments

  • Ampio Pharmaceuticals
  • Biosplice Therapeutics
  • Symic Bio
  • UnicoCell Biomed CO. LTD
  • Eupraxia Pharmaceuticals Inc.
  • Eli Lilly and Company
  • Xalud Therapeutics, Inc.
  • ICM Biotech Australia Pty Ltd.
  • Taiwan Liposomal Company
  • Gwo Xi Stem Cell Applied Technology Co., Ltd.
  • K-STEMCELL
  • Centrexion Therapeutics
  • Techfields Pharma
  • AstraZeneca
  • Monoclonal Antibody
  • Peptides
  • Polymer
  • Small molecule
  • Gene therapy
  • Application I
  • Application II
  • Application III

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Osteoarthritis Market Snapshot
          2.1.1. Global Osteoarthritis Market By Monoclonal Antibody,2019
               2.1.1.1.
               2.1.1.2.Monoclonal Antibody
               2.1.1.3.Peptides
               2.1.1.4.Polymer
               2.1.1.5.Small molecule
          2.1.2. Global Osteoarthritis Market By Application I,2019
               2.1.2.1.
               2.1.2.2.Application I I
               2.1.2.3.Application I II
          2.1.3. Global Osteoarthritis Market By End-use,2019
          2.1.4. Global Osteoarthritis Market By Geography,2019

3. Global Osteoarthritis Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Osteoarthritis Market Size (US$), By Monoclonal Antibody, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Monoclonal Antibody, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Monoclonal Antibody, 2020
     4.2. Global Osteoarthritis Market Size (US$), By Monoclonal Antibody, 2018 – 2028

5. Global Osteoarthritis Market Size (US$), By Application I, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application I, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application I, 2020
     5.2. Global Osteoarthritis Market Size (US$), By Application I, 2018 – 2028

6. Global Osteoarthritis Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Osteoarthritis Market Size (US$), By End-use, 2018 – 2028

7. Global Osteoarthritis Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Osteoarthritis Market Analysis, 2018 – 2028 
          7.2.1. North America Osteoarthritis Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Osteoarthritis Market Size (US$), By Monoclonal Antibody, 2018 – 2028
          7.2.3. North America Osteoarthritis Market Size (US$), By Application I, 2018 – 2028
          7.2.4. North America Osteoarthritis Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Osteoarthritis Market Analysis, 2018 – 2028 
          7.3.1.  Europe Osteoarthritis Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Osteoarthritis Market Size (US$), By Monoclonal Antibody, 2018 – 2028
          7.3.3. Europe Osteoarthritis Market Size (US$), By Application I, 2018 – 2028
          7.3.4. Europe Osteoarthritis Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Osteoarthritis Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Osteoarthritis Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Osteoarthritis Market Size (US$), By Monoclonal Antibody, 2018 – 2028
          7.4.3. Asia Pacific Osteoarthritis Market Size (US$), By Application I, 2018 – 2028
          7.4.4. Asia Pacific Osteoarthritis Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Osteoarthritis Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Osteoarthritis Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Osteoarthritis Market Size (US$), By Monoclonal Antibody, 2018 – 2028
          7.5.3. Latin America Osteoarthritis Market Size (US$), By Application I, 2018 – 2028
          7.5.4. Latin America Osteoarthritis Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Osteoarthritis Market Analysis, 2018 – 2028 
          7.6.1.  MEA Osteoarthritis Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Osteoarthritis Market Size (US$), By Monoclonal Antibody, 2018 – 2028
          7.6.3. MEA Osteoarthritis Market Size (US$), By Application I, 2018 – 2028
          7.6.4. MEA Osteoarthritis Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Osteoarthritis Providers
        8.4.1 Ampio Pharmaceuticals
                8.4.1.1 Business Description
                8.4.1.2 Ampio Pharmaceuticals Geographic Operations
                8.4.1.3 Ampio Pharmaceuticals Financial Information
                8.4.1.4 Ampio Pharmaceuticals Product Positions/Portfolio
                8.4.1.5 Ampio Pharmaceuticals Key Developments
        8.4.2 Biosplice Therapeutics
                8.4.2.1 Business Description
                8.4.2.2 Biosplice Therapeutics Geographic Operations
                8.4.2.3 Biosplice Therapeutics Financial Information
                8.4.2.4 Biosplice Therapeutics Product Positions/Portfolio
                8.4.2.5 Biosplice Therapeutics Key Developments
        8.4.3 Symic Bio
                8.4.3.1 Business Description
                8.4.3.2 Symic Bio Geographic Operations
                8.4.3.3 Symic Bio Financial Information
                8.4.3.4 Symic Bio Product Positions/Portfolio
                8.4.3.5 Symic Bio Key Developments
        8.4.4 UnicoCell Biomed CO. LTD
                8.4.4.1 Business Description
                8.4.4.2 UnicoCell Biomed CO. LTD Geographic Operations
                8.4.4.3 UnicoCell Biomed CO. LTD Financial Information
                8.4.4.4 UnicoCell Biomed CO. LTD Product Positions/Portfolio
                8.4.4.5 UnicoCell Biomed CO. LTD Key Developments
        8.4.5 Eupraxia Pharmaceuticals Inc.
                8.4.5.1 Business Description
                8.4.5.2 Eupraxia Pharmaceuticals Inc. Geographic Operations
                8.4.5.3 Eupraxia Pharmaceuticals Inc. Financial Information
                8.4.5.4 Eupraxia Pharmaceuticals Inc. Product Positions/Portfolio
                8.4.5.5 Eupraxia Pharmaceuticals Inc. Key Developments
        8.4.6 Eli Lilly and Company
                8.4.6.1 Business Description
                8.4.6.2 Eli Lilly and Company Geographic Operations
                8.4.6.3 Eli Lilly and Company Financial Information
                8.4.6.4 Eli Lilly and Company Product Positions/Portfolio
                8.4.6.5 Eli Lilly and Company Key Developments
        8.4.7 Xalud Therapeutics, Inc.
                8.4.7.1 Business Description
                8.4.7.2 Xalud Therapeutics, Inc. Geographic Operations
                8.4.7.3 Xalud Therapeutics, Inc. Financial Information
                8.4.7.4 Xalud Therapeutics, Inc. Product Positions/Portfolio
                8.4.7.5 Xalud Therapeutics, Inc. Key Developments
        8.4.8 ICM Biotech Australia Pty Ltd.
                8.4.8.1 Business Description
                8.4.8.2 ICM Biotech Australia Pty Ltd. Geographic Operations
                8.4.8.3 ICM Biotech Australia Pty Ltd. Financial Information
                8.4.8.4 ICM Biotech Australia Pty Ltd. Product Positions/Portfolio
                8.4.8.5 ICM Biotech Australia Pty Ltd. Key Developments
        8.4.9 Taiwan Liposomal Company
                8.4.9.1 Business Description
                8.4.9.2 Taiwan Liposomal Company Geographic Operations
                8.4.9.3 Taiwan Liposomal Company Financial Information
                8.4.9.4 Taiwan Liposomal Company Product Positions/Portfolio
                8.4.9.5 Taiwan Liposomal Company Key Developments
        8.4.10 Gwo Xi Stem Cell Applied Technology Co., Ltd.
                8.4.10.1 Business Description
                8.4.10.2 Gwo Xi Stem Cell Applied Technology Co., Ltd. Geographic Operations
                8.4.10.3 Gwo Xi Stem Cell Applied Technology Co., Ltd. Financial Information
                8.4.10.4 Gwo Xi Stem Cell Applied Technology Co., Ltd. Product Positions/Portfolio
                8.4.10.5 Gwo Xi Stem Cell Applied Technology Co., Ltd. Key Developments
        8.4.11 K-STEMCELL
                8.4.11.1 Business Description
                8.4.11.2 K-STEMCELL Geographic Operations
                8.4.11.3 K-STEMCELL Financial Information
                8.4.11.4 K-STEMCELL Product Positions/Portfolio
                8.4.11.5 K-STEMCELL Key Developments
        8.4.12 Centrexion Therapeutics
                8.4.12.1 Business Description
                8.4.12.2 Centrexion Therapeutics Geographic Operations
                8.4.12.3 Centrexion Therapeutics Financial Information
                8.4.12.4 Centrexion Therapeutics Product Positions/Portfolio
                8.4.12.5 Centrexion Therapeutics Key Developments
        8.4.13 Techfields Pharma
                8.4.13.1 Business Description
                8.4.13.2 Techfields Pharma Geographic Operations
                8.4.13.3 Techfields Pharma Financial Information
                8.4.13.4 Techfields Pharma Product Positions/Portfolio
                8.4.13.5 Techfields Pharma Key Developments
        8.4.14 AstraZeneca
                8.4.14.1 Business Description
                8.4.14.2 AstraZeneca Geographic Operations
                8.4.14.3 AstraZeneca Financial Information
                8.4.14.4 AstraZeneca Product Positions/Portfolio
                8.4.14.5 AstraZeneca Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Osteoarthritis Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Osteoarthritis Market Revenue, By Monoclonal Antibody, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Osteoarthritis Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Osteoarthritis Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Osteoarthritis Market Revenue, By Monoclonal Antibody, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Osteoarthritis Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Osteoarthritis Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Osteoarthritis Market Revenue, By Monoclonal Antibody, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Osteoarthritis Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Osteoarthritis Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Osteoarthritis Market Revenue, By Monoclonal Antibody, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Osteoarthritis Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Osteoarthritis Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Osteoarthritis Market Revenue, By Monoclonal Antibody, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Osteoarthritis Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Osteoarthritis Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Osteoarthritis: Market Segmentation 
FIG. 2 Global Osteoarthritis Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Osteoarthritis Market, By Monoclonal Antibody, 2019 (US$ Mn) 
FIG. 5 Global Osteoarthritis Market, By Application I, 2019 (US$ Mn) 
FIG. 6 Global Osteoarthritis Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Osteoarthritis Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Osteoarthritis Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Osteoarthritis Providers, 2019
FIG. 11 Global Osteoarthritis Market Revenue Contribution, By Monoclonal Antibody, 2019 & 2028 (Value %) 
FIG. 12 Global Osteoarthritis Market Revenue Contribution, By Application I, 2019 & 2028 (Value %) 
FIG. 13 Global Osteoarthritis Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Osteoarthritis Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Osteoarthritis Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Osteoarthritis Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Osteoarthritis Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Osteoarthritis Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Osteoarthritis market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Osteoarthritis Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Osteoarthritis Market Value, By Segment1, 2018 – 2028
TABLE  North America Osteoarthritis Market Value, By Segment2, 2018 – 2028
TABLE  North America Osteoarthritis Market Value, By Country, 2018 – 2028
TABLE  Europe Osteoarthritis Market Value, By Segment1, 2018 – 2028
TABLE  Europe Osteoarthritis Market Value, By Segment2, 2018 – 2028
TABLE  Europe Osteoarthritis Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Osteoarthritis Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Osteoarthritis Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Osteoarthritis Market Value, By Country, 2018 – 2028
TABLE  Latin America Osteoarthritis Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Osteoarthritis Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Osteoarthritis Market Value, By Country, 2018 – 2028
TABLE  MEA Osteoarthritis Market Value, By Segment1, 2018 – 2028
TABLE  MEA Osteoarthritis Market Value, By Segment2, 2018 – 2028
TABLE  MEA Osteoarthritis Market Value, By Country, 2018 – 2028
TABLE  Ampio Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biosplice Therapeutics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Symic Bio: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  UnicoCell Biomed CO. LTD: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eupraxia Pharmaceuticals Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eli Lilly and Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Xalud Therapeutics, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ICM Biotech Australia Pty Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Taiwan Liposomal Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Gwo Xi Stem Cell Applied Technology Co., Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  K-STEMCELL: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Centrexion Therapeutics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Techfields Pharma: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AstraZeneca: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Osteoarthritis Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Osteoarthritis Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Osteoarthritis Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Osteoarthritis Market, By Geography, 2019 (US$ Mn)
FIG.  Global Osteoarthritis Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Osteoarthritis Providers, 2016
FIG.  Global Osteoarthritis Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Monoclonal Antibody Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Peptides Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Polymer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Small molecule Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Gene therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Osteoarthritis Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Application I Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Application II Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Application III Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Osteoarthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Osteoarthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Osteoarthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Osteoarthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Osteoarthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Osteoarthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Osteoarthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Osteoarthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Osteoarthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Osteoarthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Osteoarthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Osteoarthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Osteoarthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Osteoarthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Osteoarthritis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Osteoarthritis Market Value, 2018 – 2028, (US$ Mn)